PMID- 25122057 OWN - NLM STAT- MEDLINE DCOM- 20150916 LR - 20181202 IS - 1557-8534 (Electronic) IS - 1547-3287 (Linking) VI - 24 IP - 2 DP - 2015 Jan 15 TI - Effect of FGF-2 on collagen tissue regeneration by human vertebral bone marrow stem cells. PG - 228-43 LID - 10.1089/scd.2014.0148 [doi] AB - The effects of fibroblast growth factor-2 (FGF-2) on collagen tissue regeneration by human bone marrow stem cells (hBMSCs) were investigated. hBMSCs were isolated from human vertebral body bone marrow during vertebral surgery and a population of hBMSCs with the characteristics of mesenchymal stem cells was observed. The FGF-2 treatment (5 ng/mL) affected on the colony-forming efficiency, proliferation, and in vitro differentiation of hBMSCs. Insoluble/soluble collagen and hydroxyproline synthesis was significantly enhanced in hBMSCs expanded with FGF-2 and the treatment of FGF-2 caused a reduction in the mRNA expression of collagen type I, but an increase of collagen types II and III along with lysyl oxidase family genes. Collagen formation was also examined using an in vivo assay model by transplanting hBMSCs into immunocompromised mice (n=4) and the histologic and immunohistochemical results revealed that significantly more collagen with a well-organized structure was formed by FGF-2-treated hBMSCs at 8 weeks posttransplantation (P<0.05). The DNA microarray assay demonstrated that genes related to extracellular matrix formation were significantly upregulated. To elucidate the underlying mechanism, chemical inhibitors against extracellular-signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K) were treated and following downstream expression was observed. Collectively, FGF-2 facilitated the collagen-producing potency of hBMSCs both in vitro and in vivo, rendering them more suitable for use in collagen regeneration in the clinical field. FAU - Park, Dong-Soo AU - Park DS AD - 1 Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University , Seoul, Korea. FAU - Park, Jung-Chul AU - Park JC FAU - Lee, Jung-Seok AU - Lee JS FAU - Kim, Tae-Wan AU - Kim TW FAU - Kim, Ki-Joon AU - Kim KJ FAU - Jung, Byung-Joo AU - Jung BJ FAU - Shim, Eun-Kyung AU - Shim EK FAU - Choi, Eun-Young AU - Choi EY FAU - Park, So-Yon AU - Park SY FAU - Cho, Kyoo-Sung AU - Cho KS FAU - Kim, Chang-Sung AU - Kim CS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Stem Cells Dev JT - Stem cells and development JID - 101197107 RN - 103107-01-3 (Fibroblast Growth Factor 2) RN - 9007-34-5 (Collagen) RN - EC 1.4.3.13 (Protein-Lysine 6-Oxidase) SB - IM MH - Adult MH - Animals MH - Bone Marrow Cells/cytology/*metabolism MH - Cell Differentiation/*drug effects MH - Cells, Cultured MH - Collagen/*biosynthesis MH - Female MH - Fibroblast Growth Factor 2/*pharmacology MH - Heterografts MH - Humans MH - Male MH - Mesenchymal Stem Cell Transplantation MH - Mesenchymal Stem Cells/cytology/*metabolism MH - Mice MH - Mice, SCID MH - Middle Aged MH - Protein-Lysine 6-Oxidase/biosynthesis MH - Regeneration/*drug effects MH - Spine/cytology/*metabolism EDAT- 2014/08/15 06:00 MHDA- 2015/09/17 06:00 CRDT- 2014/08/15 06:00 PHST- 2014/08/15 06:00 [entrez] PHST- 2014/08/15 06:00 [pubmed] PHST- 2015/09/17 06:00 [medline] AID - 10.1089/scd.2014.0148 [doi] PST - ppublish SO - Stem Cells Dev. 2015 Jan 15;24(2):228-43. doi: 10.1089/scd.2014.0148.